SHA:601089 Market Cap

SHA:601089 has a market cap or net worth of 11.16 billion as of March 9, 2026. Its market cap has increased by 53.18% in one year.

Market Cap

11.16B

Enterprise Value

9.14B

Revenue

3.42B

Ranking

n/a

PE Ratio

24.57

Stock Price

23.59

Market Cap Chart

Since June 30, 2022, SHA:601089's market cap has increased from 10.10B to 11.16B, an increase of 10.47%. That is a compound annual growth rate of 2.73%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	11.04B	-1.71%
Dec 31, 2025	11.23B	50.00%
Dec 31, 2024	7.49B	-9.51%
Dec 29, 2023	8.28B	12.46%
Dec 30, 2022	7.36B	-27.17%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Zhejiang CONBA Pharmaceutical	11.06B
Mayinglong Pharmaceutical Group	11.37B
Porton Pharma Solutions	11.46B
Tianjin Chase Sun Pharmaceutical Co.,Ltd	10.78B
Shanghai Yizhong Pharmaceutical	10.78B
Zhejiang Hisoar Pharmaceutical	11.87B
Yantai Dongcheng Pharmaceutical Group	10.46B
Wanbangde Pharmaceutical Holding Group	10.37B

Market Cap Rankings